期刊文献+

乌司他丁对体外循环下心脏瓣膜置换术患者外周血单个核细胞焦亡的影响 被引量:3

Effect of ulinastatin on pyrolysis of peripheral blood mononuclear cells in patients undergoing heart valve replacement under cardiopulmonary bypass
下载PDF
导出
摘要 目的探讨乌司他丁(UTI)对行体外循环(CPB)下心脏瓣膜置换术患者围术期炎性反应和外周血单个核细胞(PBMCs)焦亡的影响及其机制。方法选择行CPB下心脏瓣膜置换术患者60例,采用随机数字表法分为2组:乌司他丁组(UTI组)和生理盐水组(NS组),每组30例。UTI组患者接受总剂量为20000 U/kg的UTI,半量于手术切皮前输注完毕,另半剂量经CPB管路给药。NS组以等容量生理盐水替代。于麻醉诱导后切皮前(T_(1))、CPB开始后30 min(T_(2))、CPB停止即刻(T_(3))及停止后24 h(T_(4))时采集颈内静脉血样,采用酶联免疫吸附法(ELISA)测定血浆白细胞介素(IL)-18、IL-1β的浓度,采用Western blot法检测单核细胞中核苷酸结合寡聚化结构域样受体蛋白3(NLRP3)、半胱氨酰天冬氨酸特异性蛋白酶1(Caspase-1)及消皮素-D(GSDMD)的表达。记录术中丙泊酚用量、舒芬太尼用量、去甲肾上腺素用量、术后机械通气时间及重症监护室(ICU)停留时间。结果与T_(1)时相比,两组患者T_(2)~T_(4)时血浆IL-18、IL-1β和单核细胞NLRP3、Caspase-1、GSDMD蛋白表达均显著升高(P<0.05)。与NS组相比,UTI组T_(2)~T_(4)时血浆IL-18、IL-1β浓度和PBMCs中NLRP3、Caspase-1、GSDMD蛋白表达均显著降低(P<0.05)。两组患者术中丙泊酚用量、舒芬太尼用量、去甲肾上腺素用量及ICU停留时间差异均无统计学意义(P>0.05);UTI组术后机械通气时间较NS组显著降低,差异有统计学意义(P<0.05)。结论UTI减轻了CPB下心脏瓣膜置换术患者围术期炎性反应,其抗炎机制可能与抑制PBMCs中NLRP3、Caspase-1蛋白表达、降低其下游炎症因子IL-18、IL-1β水平、抑制PBMCs焦亡有关。 Objective To investigate the effect of ulinastatin(UTI)on perioperative inflammation and pyrolysis of peripheral blood mononuclear cells(PBMCs)and its mechanism in patients undergoing heart valve replacement under cardiopulmonary bypass(CPB).Methods A total of 60 patients undergoing heart valve replacement under CPB were divided into 2 groups by a random number table:ulinastatin group(UTI group)and normal saline group(NS group),with 30 cases in each group.Patients in the UTI group received a total dose of 20,000 U/kg of UTI,half of which was infused before surgical skin incision,and the other half of the dose was administered via the CPB line.The drug intervention of NS group was replaced with equal volume of normal saline.Blood samples from the internal jugular vein were collected before skin incision(T_(1)),30 min after starting CPB(T_(2)),immediately after stopping CPB(T_(3))and 24 h after cessation(T_(4))after induction of anesthesia,and enzyme-linked immunosorbent assay(ELISA)was used to detect the concentration of interleukin(IL)-18 and IL-1β in plasma.The expressions of nucleotide-binding oligomerization domain-like receptor protein 3(NLRP3)and cysteinyl aspartate specific protease 1(Caspase-1)in monocytes and Gasdermin-D(GSDMD)were detected by Western blot.The intraoperative dosage of propofol,sufentanil and norepinephrine,postoperative mechanical ventilation time and intensive care unit(ICU)stay time were recorded.Results Compared with T_(1),the plasma IL-18,IL-1β and monocyte NLRP3,Caspase-1,GSDMD protein expressions were significantly increased at T_(2)~T_(4) in the two groups of patients(P<0.05).Compared with the NS group,the concentrations of plasma IL-18 and IL-1β and the expression of NLRP3,Caspase-1 and GSDMD protein in PBMCs were significantly reduced at T_(2)~T_(4) in the UTI group(P<0.05).There was no significant difference in the intraoperative propofol dosage,sufentanil dosage,norepinephrine dosage,or ICU stay time between the two groups of patients(P>0.05);the postoperative mechanical ven
作者 周一鸣 惠康祥 周俊辉 涂立刚 ZHOU Yi-ming;HUI Kang-xiang;ZHOU Jun-hui;TU Li-gang(Department of Anesthesiology,Xinyang Central Hospital,Xinyang 464000,China;Department of Anesthesiology,Henan Provincial Hospital,Zhengzhou 450008,China)
出处 《实用药物与临床》 CAS 2022年第6期521-525,共5页 Practical Pharmacy and Clinical Remedies
基金 河南省重点研发与推广专项(科技攻关)项目(212102310720)。
关键词 乌司他丁 心肺转流术 炎症 NLRP3炎症小体 细胞焦亡 Ulinastatin Cardiopulmonary bypass Inflammation NLRP3 inflammasome Pyroptosis
  • 相关文献

参考文献5

二级参考文献58

  • 1王玉巧,陈永祥.乌司他丁对体外循环术后肺损伤保护作用的临床分析[J].陕西医学杂志,2008,37(12):1620-1622. 被引量:5
  • 2代庆春,韩玉,苗晓云,周晓红,沈洪丽,张晓卫.硫化氢对脂多糖所致急性肺损伤大鼠血浆和肺组织中炎性细胞因子的影响[J].中国老年学杂志,2014,34(7):1864-1867. 被引量:6
  • 3Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: Implications for the anesthesiologist. Anesthesiology 2002;97:215-52. 被引量:1
  • 4Hall RI, Smith MS, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 1997;85:766-82. 被引量:1
  • 5Ng CS, Wan S. Limiting inflammatory response to cardiopulmonary bypass: Pharmaceutical strategies. Curr Opin Pharmacol 2012;12:155-9. 被引量:1
  • 6Warren O J, Smith AJ, Alexiou C, Rogers PL, Jawad N, Vincent C, et aL The inflammatory response to cardiopulmonary bypass: Part 1 - Mechanisms of pathogenesis. J Cardiothorac Vasc Anesth 2009;23:223-31. 被引量:1
  • 7Vohra HA, Whistance R, Modi A, Ohri SK. The inflammatory response to miniaturised extracorporeal circulation: A review of the literature. Mediators Inflamm 2009;2009:707042. 被引量:1
  • 8Tang J, Tao K, Zhou J, Zhang C, Gong L, Luo N, et al. Long-term leukocyte filtration should be avoided during extracorporeal circulation. Mediators Inflamm 2013;2013:612848. 被引量:1
  • 9Nakanishi K, Takeda S, Sakamoto A, Kitamura A. Effects of ulinastatin treatment on the cardiopulmonary bypass-induced hemodynamic instability and pulmonary dysfunction. Crit Care Med 2006;34:1351-7. 被引量:1
  • 10Xu CE, Zou CW, Zhang MY, Guo L. Effects of high-dose ulinastatin on inflammatory response and pulmonary function in patients with type-A aortic dissection after eardiopulmonary bypass under deep hypothermic circulatory arrest. J Cardiothorac Vasc Anesth 2013;27:479-84. 被引量:1

共引文献58

同被引文献30

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部